CNTB Connect Biopharma Holdings Ltd
Company Analysis
Latest News
π’ Connect Biopharma is trading 6.86% up today in a rebound following a sharp selloff
Connect Biopharma is trading at $2.42 (+6.86%) in an apparent rebound following a significant decline in the previous session. β’ The stock is recovering from...
π΄ Connect Biopharma is trading 10.4% down
Connect Biopharma is trading at $2.25, down 10.4% from a comparison close of $2.51 during regular trading. This is a price-action follow-up, so a separate...
π΄ Connect Biopharma is trading 7.1% down today on profit-taking after sharp post-upgrade rally
Connect Biopharma is trading at $2.33 (7.1% down) as investors lock in gains following a sharp multi-day rally driven by bullish analyst sentiment. β’ The...
π’ Connect Biopharma is trading 5.4% up today following positive analyst coverage and an $8 price target
Connect Biopharma is trading at $2.65 (up 5.4%) as the stock rebounds from a minor pullback, supported by a wave of bullish analyst sentiment. β’ Oppenheimer...
π΄ Connect Biopharma is trading 5.6% down today on profit-taking after recent rally
Connect Biopharma is trading 5.6% down at $2.51 today, likely reflecting profit-taking and consolidation following a sharp 19.8% gain on July 9. β’ The stock...
π’ Connect Biopharma Holdings Ltd is trading 5.45% up
CNTB is trading at $2.81, up 5.45%.
π’ Connect Biopharma is trading 13.5% up
Connect Biopharma is trading at $2.52, up 13.5% from a comparison close of $2.22 during regular trading. This is a price-action follow-up, so a separate...
Connect Biopharma Jumps 7% on Wall Street Cheerleading, but Can a $149 Million Company Really Take On Dupixent's $16 Billion Empire?
Shares of Connect Biopharma surged 7.2% to $2.38 as renewed analyst endorsements and anticipation around mid-2026 clinical data breathed life into a stock that...
π’ Connect Biopharma is trading 7.2% up today on renewed analyst optimism and pipeline progress
Connect Biopharma is trading 7.2% up now at $2.38 following renewed analyst optimism and ongoing interest in its inflammatory disease pipeline. β’ Oppenheimer...
π’ Connect Biopharma Holdings Ltd is trading 6.83% up in pre-market
CNTB is trading at $2.37, up 6.83% in pre-market.
π’ CNTB is trading 11.8% up today following an after-hours recovery and recent volatility
CNTB is trading 11.8% up at $2.47 in pre-market following an after-hours recovery and recent volatility. β’ The stock closed at $2.21 on July 7 after falling...
π’ CNTB is trading 5.9% up today on after-hours rebound following profit-taking pullback
CNTB is trading at $2.34, up 5.9% in after-hours action, as the stock stages a modest recovery following a decline during the regular session. β’ The stock...
π΄ CNTB is trading 5.5% down today on profit-taking after a speculative rally
CNTB is trading 5.5% down at $2.23 as the stock undergoes a pullback following a sharp speculative rally in late June and early July. β’ The decline appears to...
π’ CNTB is trading 8.5% up today as it extends its late-June rally despite a lack of fresh news
CNTB is trading at $2.56 (8.5% up) in pre-market, rebounding from yesterdayβs 4.1% drop and extending its recent late-June rally. β’ No fresh company-specific...
π΄ CNTB is trading 5.3% down today on no clear news catalyst
CNTB is trading at $2.33 (-5.28%) in pre-market action following a quiet news scan that found no clear company-specific catalyst for the move. β’ The decline...
π’ CNTB is trading 6% up in pre-market driven by recent biotech momentum and asthma study progress
CNTB is trading at $2.53 (+5.96%) in pre-market after extending its late-June rally. The latest move follows recent momentum in the shares and comes after the...
π’ CNTB is trading 5% up today, extending recent momentum from late June
CNTB is trading 5% up at $2.50, continuing a multi-day rally as the stock builds on strength established in late June. β’ The move appears to be a continuation...
π’ CNTB is trading 5% up today following bullish analyst initiation and recent insider buying
CNTB is trading 5% up at $2.30, extending a multi-day rebound from recent lows as positive analyst coverage and insider activity boost investor sentiment. β’...
π’ CNTB is trading 11.4% up today, extending a rebound following recent insider buying
CNTB is trading 11.4% up at $2.44 in pre-market, extending a strong rebound from recent lows despite a lack of fresh company-specific news or filings this...
π’ CNTB makes sharp 10.9% jump
CNTB is trading at $2.29, up 10.9% versus the comparison close of $2.07 during regular trading. This is a price-movement alert; no separate company-specific...